TRB Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.46M Buy
2,986
+166
+6% +$196K 0.48% 39
2026
Q2
$3.38M Sell
2,820
-1,585
-36% -$1.62M 0.45% 39
2026
Q1
$4.05M Buy
+4,405
New +$4.47M 0.58% 33

Other funds holding LLY

TRB Wealth Management's LLY Position: Q3 2026 in Review

TRB Wealth Management increased its Eli Lilly (LLY) stake by 5.9% in Q3 2026, buying an estimated $196K and bringing the position to 2,986 shares worth $3.46M. The position accounts for 0.48% of the portfolio, ranked #39.

TRB Wealth Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.05M in Q1 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • TRB Wealth Management held 2,986 shares of Eli Lilly worth $3.46M as of Q3 2026.
  • TRB Wealth Management bought 166 Eli Lilly shares in Q3 2026, an estimated $196K.
  • Eli Lilly made up 0.48% of TRB Wealth Management's portfolio in Q3 2026, its #39 holding.
  • TRB Wealth Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • TRB Wealth Management's Eli Lilly position peaked at $4.05M in Q1 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.